相关实验视频

Updated: May 21, 2025

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Published on: September 5, 2019

限制诱导的ROS积累对高度灵活的癌细胞和非癌细胞的差异影响

William Collins Keith¹, Farnaz Hemmati¹, Ravi Sureshbhai Vaghasiya¹

¹Department of Chemical Engineering, Auburn University, Auburn AL, 36849, USA.

AIChE journal. American Institute of Chemical Engineers

|March 18, 2025

概括

限制细胞迁移增加了反应性氧物种 (ROS). 抗氧化剂治疗减少ROS,抑制DNA损伤反应,并有助于癌细胞迁移,这表明抗氧化剂可能促进瘤的进展.

科学领域:

细胞生物学细胞生物学
生物物理学的生物物理.
癌症研究癌症研究

背景情况:

活体细胞遇到空间限制,导致变形和潜在的DNA损伤.
监禁导致的DNA损伤与活性氧物种 (ROS) 的增加有关.

研究的目的:

为了研究氧化应激对受空间限制的细胞行为的影响.
探索ROS在受限诱导的细胞反应和迁移中的作用.

主要方法:

使用微通道设备来控制细胞封闭程度和持续时间.
在HT-1080纤维瘤细胞和人类皮肤纤维细胞中测量了ROS水平.
评估了N-乙-L-氨酸 (NAC) 抗氧化治疗对细胞反应的影响.

主要成果:

隔离在癌症和正常细胞中显著增加了ROS水平.
NAC治疗降低了ROS,抑制了p53激活,并提高了细胞存活率.
在封闭的癌细胞中,NAC优先减少背部周核性动蛋白纤维,与减少核破裂和增加迁移相关.

结论:

氧化应激在癌细胞与非癌细胞对禁闭的反应中起着不同的作用.
抗氧化剂干预可能无意中通过增强癌细胞迁移来支持瘤进展.

更多相关视频

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

Published on: August 12, 2018

Detection of Total Reactive Oxygen Species in Adherent Cells by 2',7'-Dichlorodihydrofluorescein Diacetate Staining

Detection of Total Reactive Oxygen Species in Adherent Cells by 2',7'-Dichlorodihydrofluorescein Diacetate Staining

Published on: June 23, 2020

相关概念视频

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...